K Number
K973538
Device Name
N-TERFACE
Date Cleared
1997-12-16

(89 days)

Product Code
Regulation Number
N/A
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
N-TERFACE Interpositional Surfacing Material is indicated for use as a wound contact layer for partial thickness burns and and confection worselves of laser skin resurfacing. indicated for use as a wound concace in ......................................................................................................................................
Device Description
N-TERFACE® Interpositional Surfacing Material is an extruded, non-woven, high density polyethylene sheeting material with the following physical properties: Weight, oz/yd2: 0.36 to 0.8, Thickness, Mils: 4.0 to 5.0, Tensile, Ibs/in .: roll direction 14 to 77, cross direction 1.5 to 4.5, Air Permeability ft3/min/ft2: 545 to 1144.
More Information

Not Found

No
The summary describes a physical material with specific physical properties and does not mention any software, algorithms, or data processing capabilities that would indicate the use of AI or ML.

Yes
The device is indicated for use as a wound contact layer for partial thickness burns and laser skin resurfacing, which are therapeutic applications.

No
The device is described as an "Interpositional Surfacing Material" for wound contact, which is a therapeutic rather than a diagnostic function. There is no mention of it being used to identify or analyze a condition.

No

The device description clearly states it is a physical material (extruded, non-woven, high density polyethylene sheeting material) with physical properties like weight, thickness, tensile strength, and air permeability. This indicates it is a hardware device, not software.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use clearly states it's for use as a wound contact layer for partial thickness burns and laser skin resurfacing. This is a therapeutic application, not a diagnostic one. IVDs are used to examine specimens from the human body to provide information for diagnosis, monitoring, or screening.
  • Device Description: The description details the physical properties of a material (polyethylene sheeting) used as a wound dressing. It doesn't describe any components or processes related to analyzing biological samples.
  • Lack of Diagnostic Information: There is no mention of analyzing samples, detecting biomarkers, or providing diagnostic information.

Therefore, the N-TERFACE Interpositional Surfacing Material is a medical device used for wound management, not an in vitro diagnostic device.

N/A

Intended Use / Indications for Use

N-TERFACH interpositional Surfacing Matcrial is indicated for use as a wound contact layer for partial thickness burns and and confection worselves of laser skin resurfacing. indicated for use as a wound concace in ......................................................................................................................................

Product codes (comma separated list FDA assigned to the subject device)

MGP

Device Description

N-TERFACE® Interpositional Surfacing Material is an extruded, non-woven, high density polyethylene sheeting material with the following physical properties: Weight, oz/yd2: 0.36 to 0.8, Thickness, Mils: 4.0 to 5.0, Tensile, Ibs/in .: roll direction 14 to 77, cross direction 1.5 to 4.5, Air Permeability ft3/min/ft2: 545 to 1144.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Not Found

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K820198

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

N/A

0

473538

DEC 1997

510 (k) Summary as required by 807.92(c) for N-TERFACE® Interpositional Surfacing Material Prepared July 10, 1997

| Submitted by: | Winfield Laboratories, Inc.
10488 Brockwood Road
Dallas, Texas 75238
214/553-8072 |
|-----------------|--------------------------------------------------------------------------------------------|
| Contact Person: | Gary W. Cummings
Executive Vice President |

Device Trade Name: N-TERFACE® Interpositional Surfacing Material.

Wound contact layers have not been classified. Classification:

  • N-TERFACE® Interpositional Surfacing Material Predicate Device: manufactured by Winfield Laboratories, Inc., 10488 Brockwood Road, Dallas, TX 75238. (K820198).
    Description of Device:

N-TERFACE® Interpositional Surfacing Material is an extruded, non-woven, high density polyethylene sheeting material with the following physical properties: Weight, oz/yd2: 0.36 to 0.8, Thickness, Mils: 4.0 to 5.0, Tensile, Ibs/in .: roll direction 14 to 77, cross direction 1.5 to 4.5, Air Permeability ft3/min/ft2: 545 to 1144.

Intended Use of Device:

N-TERFACE® Interpositional Surfacing Material is intended for use as the primary wound contact layer after laser skin resurfacing.

1

K473338

Substantial Equivalence to Predicate Device:

N-TERFACE Interpositional Surfacing Material indicated for use in laser skin resurfacing is physically identical to N-TERFACE® Interpositional Surfacing Material (K820198) indicated for use in the treatment of partial thickness burns. The wounds created in laser skin resurfacing are partial thickness burns. The material with this new explicit indication for a subset of the previously cleared use is therefore substantially equivalent to the device described in K820198.

2

Image /page/2/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a circular design with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the top half of the circle. Inside the circle is an abstract symbol resembling an eagle or bird in flight, composed of three stylized human profiles facing to the right. The profiles are stacked on top of each other, creating a sense of depth and movement.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

DEC 1 6 1997

Mr. Gary W. Cummings Executive Vice President Winfield Laboratories, Inc. 10488 Brockwood Road Dallas, Texas 75238

Re: K973538

N-TERFACE™ Interpositional Surfacing Material Regulatory Class: Unclassified Product Code: MGP Dated: September 18, 1997 Received: September 18, 1997

Dear Mr. Cummings:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act). You may, therefore, market your device subject to the general controls provisions of the Federal Food. Drug, and Cosmetic Act (Act) and the following limitations:

    1. This device may not be labeled for use on third degree burns.
    1. This device may not be labeled as having any accelerating effect on the rate of wound healing or epithelization.
    1. This device may not be labeled as a long-term, permanent, or no-change dressing, or as an artificial (synthetic) skin.
    1. This device may not be labeled as a treatment or a cure for any type of wound.

The labeling claims listed above would be considered a major modification in the intended use of the device and would require a premarket notification submission (21 CFR 807.81).The general controls provisions of the Act include requirements for annual

3

Page 2 - Mr. Gary W. Cummings

registration, listing of devices, good manufacturing practices, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval) it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations (CFR), Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Good Manufacturing Practices (GMP) for Medical Devices: General GMP regulation (21 CFR Part 820) and that, through periodic GMP inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices). please contact the Office of Compliance at (301) 594-4595. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or 301-443-6597 or at its internet address http://www.fda.gov/cdrh/dsmamain.html.

Sincerely yours,

a M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

4

SIAK) Number (if known):K973538
-----------------------------------

N-TERFACE Interpositional Surfacing MaterialDevice Name:

Indications For Usc:

· ·· . . ・・ ・・・

N-TERFACH interpositional Surfacing Matcrial is indicated for use as a wound contact layer for partial thickness burns
and and confection worselves of laser skin resurfacing. indicated for use as a wound concace in ......................................................................................................................................

(I'LEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IT NEEDED)

Coucurrence of CDRH, Office of Device Evaluation (ODE)

(Division Sign-Off)

Division of General Restorative Devices 12973534 510(k) Number

Prescription Use
(Per 21 CFR 801.109)

ીર

Over-The-Counter Use

(Optional Formal 1-2-96)